The inhibition of Gli1 expression decreases ABCB1 and ABCG2 gene expression levels, thus enhancing the response of ovarian cancer cells to certain chemotherapeutic drugs (Chen et al., 2014). Here, ABCG2 is linked to ovarian cancer.